
VolitionRx Limited VNRX
$ 0.2
-2.22%
Quarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited P/E Ratio 2011-2026 | VNRX
Annual P/E Ratio VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.01 | -1.63 | -2.91 | -5.82 | - | -11.5 | -4.43 | -6.27 | -8.98 | -7.01 | -8.18 | -7.3 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.63 | -11.5 | -6 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
-0.00947 | $ 2.86 | -3.38 % | $ 92.8 K | ||
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
34.7 | $ 118.89 | 0.64 % | $ 36.1 B | ||
|
Fulgent Genetics
FLGT
|
-10.9 | $ 13.75 | -3.17 % | $ 416 M | ||
|
ICON Public Limited Company
ICLR
|
21 | $ 107.73 | -0.5 % | $ 8.89 B | ||
|
IDEXX Laboratories
IDXX
|
48.3 | $ 636.84 | 0.02 % | $ 51.2 B | ||
|
Illumina
ILMN
|
-13.4 | $ 130.15 | -2.06 % | $ 20.7 B | ||
|
Celcuity
CELC
|
-3.57 | $ 108.05 | -0.24 % | $ 4.26 B | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
38.9 | $ 27.48 | -1.84 % | $ 763 M | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 283.25 | -1.05 % | $ 23.6 B | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 79.36 | 4.01 % | $ 5.36 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 175.2 | -1.93 % | $ 8.68 B | ||
|
Mettler-Toledo International
MTD
|
32.7 | $ 1 318.91 | -0.31 % | $ 27.2 B | ||
|
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 5.21 | 3.89 % | $ 482 M | ||
|
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | ||
|
NeoGenomics
NEO
|
-13.7 | $ 9.59 | 0.89 % | $ 1.23 B | ||
|
Natera
NTRA
|
-9.69 | $ 208.22 | 4.02 % | $ 20.5 B | ||
|
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | ||
|
Pacific Biosciences of California
PACB
|
-0.911 | $ 1.52 | -6.17 % | $ 456 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Precipio
PRPO
|
-1.49 | $ 24.7 | 0.08 % | $ 32.1 M | ||
|
Biodesix
BDSX
|
-2.14 | $ 15.67 | -0.51 % | $ 2.03 B | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 6.82 | -17.66 % | $ 285 M | ||
|
Sotera Health Company
SHC
|
61 | $ 15.74 | -1.06 % | $ 4.47 B | ||
|
Soleno Therapeutics
SLNO
|
99.7 | $ 38.17 | -2.28 % | $ 1.94 B | ||
|
BioNano Genomics
BNGO
|
-0.0317 | $ 1.12 | -2.19 % | $ 1.42 M | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 208.58 | -0.79 % | $ 23.2 B | ||
|
Danaher Corporation
DHR
|
41.4 | $ 204.29 | -0.83 % | $ 146 B | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | $ 103.36 | - | $ 19.5 B | ||
|
Bioventus
BVS
|
-2.25 | $ 8.78 | 0.11 % | $ 550 M | ||
|
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.3 | -4.19 % | $ 292 M | ||
|
DexCom
DXCM
|
30.5 | $ 72.86 | -1.24 % | $ 28.4 B | ||
|
Thermo Fisher Scientific
TMO
|
29.3 | $ 507.94 | -0.1 % | $ 191 B | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 47.14 | 2.72 % | $ 2.82 B | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 24.01 | -6.38 % | $ 254 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 18.74 | -0.03 % | $ 999 M | ||
|
Waters Corporation
WAT
|
30.6 | $ 311.27 | 1.35 % | $ 18.5 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
Guardant Health
GH
|
-32.3 | $ 94.75 | 2.73 % | $ 11.9 B | ||
|
IQVIA Holdings
IQV
|
20.8 | $ 173.82 | -0.27 % | $ 29.9 B |